Concentra Reports Strong Q4, Projects FY2026 Revenue

Concentra Group Holdings (NYSE:CON) reported a stronger-than-expected Q4 and on Feb. 2 RBC Capital raised its price target to $31 while maintaining an Outperform rating. On Jan. 28 Concentra projected FY2026 revenue of $2.25–2.35 billion, near the $2.32 billion consensus, and on Jan. 26 opened a new Georgia medical center to expand occupational health and telemedicine services.
Scoring Rationale
Official guidance and analyst upgrade support a credible investment signal, limited by company-specific scope and modest novelty.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems


